Ad
Wednesday, 28 August 2019
FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients
The U.S. Food and Drug Administration said on Wednesday it had identified 63 cases of worsening liver function in certain patients taking hepatitis C medicines made by drugmakers Merck & Co Inc, Gilead Sciences and AbbVie Inc.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment